Nonobstructive coronary disease leading to STEMI: assessment of residual stenosis after thrombus aspiration

Pedro De Araújo Gonçalves1, João Brito, Pedro Jeronimo Sousa

  • 1Cardiology Department, Santa Cruz Hospital, West Lisbon Hospital Center, Lisbon, Portugal. paraujogoncalves@yahoo.co.uk

Coronary Artery Disease
|December 18, 2012
PubMed

Insights

A significant portion of ST-elevation myocardial infarction (STEMI) patients had nonobstructive residual stenosis after thrombus aspiration. These patients were younger with less multivessel disease, indicating earlier atherosclerosis stages.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Atherosclerosis Research

Background:

  • Nonobstructive coronary atherosclerotic lesions can precipitate ST-elevation myocardial infarction (STEMI).
  • Thrombus aspiration during primary percutaneous coronary intervention (PCI) allows for evaluation of culprit lesion stenosis.
  • Understanding residual stenosis is crucial for STEMI management.

Purpose of the Study:

  • To assess the degree of residual stenosis in culprit lesions after thrombus aspiration in STEMI patients.
  • To compare demographic, clinical, and angiographic features of patients with obstructive versus nonobstructive residual stenosis.

Main Methods:

  • Analysis of a single-center registry of 483 STEMI patients undergoing primary PCI.
  • 172 patients who underwent thrombus aspiration were categorized into two groups based on residual stenosis (<50% or >=50%).
  • Multivariable analysis identified predictors of nonobstructive residual stenosis.

Main Results:

  • 69% (n=119) had residual stenosis >=50% (obstructive), while 31% (n=53) had <50% (nonobstructive).
  • Patients with nonobstructive residual stenosis (<50%) had significantly lower prevalence of multivessel disease (15.1% vs 46.2%, P<0.001).
  • Absence of vascular disease (OR 4.99) and age <59 years (OR 2.67) independently predicted nonobstructive residual stenosis.

Conclusions:

  • A notable proportion of STEMI patients exhibit nonobstructive residual stenosis post-thrombus aspiration.
  • These patients are characterized by younger age, lower prevalence of multivessel disease, and absence of vascular disease.
  • Findings suggest these patients may represent an earlier stage of atherosclerotic disease progression.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...